Sorry, your browser doesn't support embedded videos.This video, illustrating each sequential SD-OCT B-scan image, highlights the size and location of the subfoveal lesion observed in the right eye. .fusion-fullwidth.fusion-builder-row-3 … [Read more...] about Case #71: Focal Choroidal Excavation: A Rare Sequela of Myopia? – Page 6 of 22
News
Case #71: Focal Choroidal Excavation: A Rare Sequela of Myopia? – Page 5 of 22
Retinal Imaging Findings: SD-OCT imaging of the left eye revealed not one but two analogous parafoveal focal choroidal excavations, one directly superior and one inferotemporal to the fovea. Like the right eye, these two lesions both appeared to have conforming overlying sensory retinal layers. .fusion-fullwidth.fusion-builder-row-4 … [Read more...] about Case #71: Focal Choroidal Excavation: A Rare Sequela of Myopia? – Page 5 of 22
Case #71: Focal Choroidal Excavation: A Rare Sequela of Myopia? – Page 3 of 22 Copy
Background: Focal Choroidal Excavation (FCE) is a relatively recently described chorioretinal anomaly first reported by Jampol et al. in 2006 1. Margolis et al. (2011)2 later introduced the term FCE in a retrospective case series of 12 patients. Herein, we describe an interesting case of an incidental findings of bilateral FCE in an otherwise healthy, asymptomatic 22-year-old … [Read more...] about Case #71: Focal Choroidal Excavation: A Rare Sequela of Myopia? – Page 3 of 22 Copy
Case #71: Focal Choroidal Excavation: A Rare Sequela of Myopia? – Page 4 of 22
Retinal Imaging Findings: Focal Choroidal Excavation (FCE) is a relatively recently described chorioretinal anomaly first reported by Jampol et al. in 2006 1. Margolis et al. (2011)2 later introduced the term FCE in a retrospective case series of 12 patients. Herein, we describe an interesting case of an incidental findings of bilateral FCE in an otherwise healthy, … [Read more...] about Case #71: Focal Choroidal Excavation: A Rare Sequela of Myopia? – Page 4 of 22
Case #71: Focal Choroidal Excavation: A Rare Sequela of Myopia? – Page 3 of 22
Background: Focal Choroidal Excavation (FCE) is a relatively recently described chorioretinal anomaly first reported by Jampol et al. in 2006 1. Margolis et al. (2011)2 later introduced the term FCE in a retrospective case series of 12 patients. Herein, we describe an interesting case of an incidental findings of bilateral FCE in an otherwise healthy, asymptomatic 22-year-old … [Read more...] about Case #71: Focal Choroidal Excavation: A Rare Sequela of Myopia? – Page 3 of 22
Case #71: Focal Choroidal Excavation: A Rare Sequela of Myopia? – Page 2 of 22
Background: Focal Choroidal Excavation (FCE) is a relatively recently described chorioretinal anomaly first reported by Jampol et al. in 2006 1. Margolis et al. (2011)2 later introduced the term FCE in a retrospective case series of 12 patients. Herein, we describe an interesting case of an incidental findings of bilateral FCE in an otherwise healthy, asymptomatic 22-year-old … [Read more...] about Case #71: Focal Choroidal Excavation: A Rare Sequela of Myopia? – Page 2 of 22
Case #71: Focal Choroidal Excavation: A Rare Sequela of Myopia? – Page 1 of 22
Focal Choroidal Excavation: A Rare Sequela of Myopia? Sorry, your browser doesn't support embedded videos..fusion-fullwidth.fusion-builder-row-4 … [Read more...] about Case #71: Focal Choroidal Excavation: A Rare Sequela of Myopia? – Page 1 of 22
Viridian announces topline data from THRIVE-2 phase 3 clinical trial of veligrotug for treatment of thyroid eye disease
Viridian Therapeutics has announced topline data from THRIVE-2, (NCT06021054) its phase 3 clinical trial of VRDN-001 (veligrotug), an intravenously delivered anti-insulin-like growth factor-1 receptor (IGF-1R) antibody, in patients with chronic thyroid eye disease (TED).THRIVE-2 is a randomized, double-masked, placebo-controlled safety, tolerability and efficacy study of … [Read more...] about Viridian announces topline data from THRIVE-2 phase 3 clinical trial of veligrotug for treatment of thyroid eye disease
VIDEO: OmniVu IOL shows positive near, intermediate and distance vision at 2 years
December 18, 2024 2 min watch CHICAGO — In this Healio Video Perspective from the AAO meeting, George O. Waring IV, MD, FACS, presents first-in-human 2-year data for the OmniVu dual-optic modular IOL for presbyopia correction at the time of cataract surgery. Manifest refraction spherical equivalent over 2 years with the OmniVu IOL (Atia … [Read more...] about VIDEO: OmniVu IOL shows positive near, intermediate and distance vision at 2 years
Aurion Biotech announces topline results from Phase 1/2 trial of AURN001 for corneal edema
Aurion Biotech Inc. has released topline data from its Phase 1/2 CLARA clinical trial (NCT06041256) evaluating AURN001, an allogeneic cell therapy product candidate for the treatment of corneal edema secondary to corneal endothelial dysfunction.According to the company, AURN001 combines allogeneic human corneal endothelial cells (neltependocel) and a rho kinase inhibitor … [Read more...] about Aurion Biotech announces topline results from Phase 1/2 trial of AURN001 for corneal edema